New

Immunomodulators Market

2021

Immunomodulators Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Immunosuppressant, Immunostimulants); Application (Oncology, Respiratory, HIV, Others) and Geography

| Report Code: TIPRE00004066 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Immunomodulators Market 2028 By Product, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Drugs that stimulate or suppress the immune system are known as immunomodulators. They alter the immune system, resulting in a change in immunological response. Immunomodulators work by reducing the formation of antibodies that react to foreign antigens and cause immunological responses. Immunomodulators are divided into two categories: immunosuppressants and immunostimulants. Corticosteroids, thymosin, and immunoglobulins are examples of immunomodulators. These medications are used for the treatment of infection, cancer, asthma and other diseases. Immunosuppressants are commonly used to avoid organ rejection during various transplant procedures. Immunostimulants could potentially be utilised to treat HIV and cancer.

MARKET SCOPE



The "Global Immunomodulators Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the immunomodulators market with detailed market segmentation by product and application. The report provides key statistics on the market status of the leading immunomodulators market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product the market is segmented as, Immunosuppressant and Immunostimulants. Immunosuppressant market is further segmented into antibodies, antimetabolites, calcineurin inhibitors, glucocorticoid and others. Immunostimulants market is further segmented into vaccines, antibodies and others.
  • Based on application the market is segmented as, oncology, respiratory, HIV and others.

MARKET DYNAMICS


Drivers:



  • The increasing use of monoclonal antibodies to treat disorders such as multiple sclerosis, Crohn's disease, rheumatoid arthritis, and others, as well as the increased prevalence of cancer, are two major factors driving market growth.
  • Furthermore, the market's growth is fueled by the availability of an effective product pipeline from companies involved in R&D of immunomodulators.

Restraints:



  • However, presence of stringent regulatory approval procedure along with high cost of the therapy are likley to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The immunomodulators market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the immunomodulators market in these regions.

IMPACT OF COVID-19 ON IMMUNOMODULATORS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the immunomodulators market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from immunomodulators market are anticipated to lucrative growth opportunities in the future with the rising demand for immunomodulators in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the immunomodulators market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • F. Hoffmann-La Roche Ltd
  • Amgen, Inc.
  • Abbott
  • Johnson and Johnson
  • Novartis AG
  • Bristol-Myers Squibb Company
  • Merck Sharp and Dohme Corp
  • Lilly
  • Pfizer Inc.
  • Biogen
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Immunomodulators Market - By Product
    1.3.2 Immunomodulators Market - By Application
    1.3.3 Immunomodulators Market - By Region
    1.3.3.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. IMMUNOMODULATORS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. IMMUNOMODULATORS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. IMMUNOMODULATORS MARKET - GLOBAL MARKET ANALYSIS
    6.1. IMMUNOMODULATORS - GLOBAL MARKET OVERVIEW
    6.2. IMMUNOMODULATORS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. IMMUNOMODULATORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
    7.1. OVERVIEW
    7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
    7.3. IMMUNOSUPPRESSANT
    7.3.1. Overview
    7.3.2. Immunosuppressant Market Forecast and Analysis
    7.3.3. Antibodies Market
    7.3.3.1. Overview
    7.3.3.2. Antibodies Market Forecast and Analysis
    7.3.4. Antimetabolites Market
    7.3.4.1. Overview
    7.3.4.2. Antimetabolites Market Forecast and Analysis
    7.3.5. Calcineurin inhibitors Market
    7.3.5.1. Overview
    7.3.5.2. Calcineurin inhibitors Market Forecast and Analysis
    7.3.6. Glucocorticoid Market
    7.3.6.1. Overview
    7.3.6.2. Glucocorticoid Market Forecast and Analysis
    7.3.7. Others Market
    7.3.7.1. Overview
    7.3.7.2. Others Market Forecast and Analysis
    7.4. IMMUNOSTIMULANTS
    7.4.1. Overview
    7.4.2. Immunostimulants Market Forecast and Analysis
    7.4.3. Vaccines Market
    7.4.3.1. Overview
    7.4.3.2. Vaccines Market Forecast and Analysis
    7.4.4. Antibodies Market
    7.4.4.1. Overview
    7.4.4.2. Antibodies Market Forecast and Analysis
    7.4.5. Others Market
    7.4.5.1. Overview
    7.4.5.2. Others Market Forecast and Analysis
    8. IMMUNOMODULATORS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    8.1. OVERVIEW
    8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    8.3. ONCOLOGY
    8.3.1. Overview
    8.3.2. Oncology Market Forecast and Analysis
    8.4. RESPIRATORY
    8.4.1. Overview
    8.4.2. Respiratory Market Forecast and Analysis
    8.5. HIV
    8.5.1. Overview
    8.5.2. HIV Market Forecast and Analysis
    8.6. OTHERS
    8.6.1. Overview
    8.6.2. Others Market Forecast and Analysis

    9. IMMUNOMODULATORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Immunomodulators Market Overview
    9.1.2 North America Immunomodulators Market Forecasts and Analysis
    9.1.3 North America Immunomodulators Market Forecasts and Analysis - By Product
    9.1.4 North America Immunomodulators Market Forecasts and Analysis - By Application
    9.1.5 North America Immunomodulators Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Immunomodulators Market
    9.1.5.1.1 United States Immunomodulators Market by Product
    9.1.5.1.2 United States Immunomodulators Market by Application
    9.1.5.2 Canada Immunomodulators Market
    9.1.5.2.1 Canada Immunomodulators Market by Product
    9.1.5.2.2 Canada Immunomodulators Market by Application
    9.1.5.3 Mexico Immunomodulators Market
    9.1.5.3.1 Mexico Immunomodulators Market by Product
    9.1.5.3.2 Mexico Immunomodulators Market by Application
    9.2. EUROPE
    9.2.1 Europe Immunomodulators Market Overview
    9.2.2 Europe Immunomodulators Market Forecasts and Analysis
    9.2.3 Europe Immunomodulators Market Forecasts and Analysis - By Product
    9.2.4 Europe Immunomodulators Market Forecasts and Analysis - By Application
    9.2.5 Europe Immunomodulators Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Immunomodulators Market
    9.2.5.1.1 Germany Immunomodulators Market by Product
    9.2.5.1.2 Germany Immunomodulators Market by Application
    9.2.5.2 France Immunomodulators Market
    9.2.5.2.1 France Immunomodulators Market by Product
    9.2.5.2.2 France Immunomodulators Market by Application
    9.2.5.3 Italy Immunomodulators Market
    9.2.5.3.1 Italy Immunomodulators Market by Product
    9.2.5.3.2 Italy Immunomodulators Market by Application
    9.2.5.4 Spain Immunomodulators Market
    9.2.5.4.1 Spain Immunomodulators Market by Product
    9.2.5.4.2 Spain Immunomodulators Market by Application
    9.2.5.5 United Kingdom Immunomodulators Market
    9.2.5.5.1 United Kingdom Immunomodulators Market by Product
    9.2.5.5.2 United Kingdom Immunomodulators Market by Application
    9.2.5.6 Rest of Europe Immunomodulators Market
    9.2.5.6.1 Rest of Europe Immunomodulators Market by Product
    9.2.5.6.2 Rest of Europe Immunomodulators Market by Application
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Immunomodulators Market Overview
    9.3.2 Asia-Pacific Immunomodulators Market Forecasts and Analysis
    9.3.3 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Product
    9.3.4 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Application
    9.3.5 Asia-Pacific Immunomodulators Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Immunomodulators Market
    9.3.5.1.1 Australia Immunomodulators Market by Product
    9.3.5.1.2 Australia Immunomodulators Market by Application
    9.3.5.2 China Immunomodulators Market
    9.3.5.2.1 China Immunomodulators Market by Product
    9.3.5.2.2 China Immunomodulators Market by Application
    9.3.5.3 India Immunomodulators Market
    9.3.5.3.1 India Immunomodulators Market by Product
    9.3.5.3.2 India Immunomodulators Market by Application
    9.3.5.4 Japan Immunomodulators Market
    9.3.5.4.1 Japan Immunomodulators Market by Product
    9.3.5.4.2 Japan Immunomodulators Market by Application
    9.3.5.5 South Korea Immunomodulators Market
    9.3.5.5.1 South Korea Immunomodulators Market by Product
    9.3.5.5.2 South Korea Immunomodulators Market by Application
    9.3.5.6 Rest of Asia-Pacific Immunomodulators Market
    9.3.5.6.1 Rest of Asia-Pacific Immunomodulators Market by Product
    9.3.5.6.2 Rest of Asia-Pacific Immunomodulators Market by Application
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Immunomodulators Market Overview
    9.4.2 Middle East and Africa Immunomodulators Market Forecasts and Analysis
    9.4.3 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Product
    9.4.4 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Application
    9.4.5 Middle East and Africa Immunomodulators Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Immunomodulators Market
    9.4.5.1.1 South Africa Immunomodulators Market by Product
    9.4.5.1.2 South Africa Immunomodulators Market by Application
    9.4.5.2 Saudi Arabia Immunomodulators Market
    9.4.5.2.1 Saudi Arabia Immunomodulators Market by Product
    9.4.5.2.2 Saudi Arabia Immunomodulators Market by Application
    9.4.5.3 U.A.E Immunomodulators Market
    9.4.5.3.1 U.A.E Immunomodulators Market by Product
    9.4.5.3.2 U.A.E Immunomodulators Market by Application
    9.4.5.4 Rest of Middle East and Africa Immunomodulators Market
    9.4.5.4.1 Rest of Middle East and Africa Immunomodulators Market by Product
    9.4.5.4.2 Rest of Middle East and Africa Immunomodulators Market by Application
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Immunomodulators Market Overview
    9.5.2 South and Central America Immunomodulators Market Forecasts and Analysis
    9.5.3 South and Central America Immunomodulators Market Forecasts and Analysis - By Product
    9.5.4 South and Central America Immunomodulators Market Forecasts and Analysis - By Application
    9.5.5 South and Central America Immunomodulators Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Immunomodulators Market
    9.5.5.1.1 Brazil Immunomodulators Market by Product
    9.5.5.1.2 Brazil Immunomodulators Market by Application
    9.5.5.2 Argentina Immunomodulators Market
    9.5.5.2.1 Argentina Immunomodulators Market by Product
    9.5.5.2.2 Argentina Immunomodulators Market by Application
    9.5.5.3 Rest of South and Central America Immunomodulators Market
    9.5.5.3.1 Rest of South and Central America Immunomodulators Market by Product
    9.5.5.3.2 Rest of South and Central America Immunomodulators Market by Application

    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    11. IMMUNOMODULATORS MARKET, KEY COMPANY PROFILES
    11.1. F. HOFFMANN-LA ROCHE LTD.
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. AMGEN, INC.
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. ABBOTT
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. JOHNSON AND JOHNSON
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. NOVARTIS AG
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. BRISTOL-MYERS SQUIBB COMPANY
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. MERCK SHARP AND DOHME CORP
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. LILLY
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. PFIZER INC.
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. BIOGEN
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments

    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    1. F. Hoffmann-La Roche Ltd.
    2. Amgen, Inc.
    3. Abbott
    4. Johnson and Johnson
    5. Novartis AG
    6. Bristol-Myers Squibb Company
    7. Merck Sharp and Dohme Corp
    8. Lilly
    9. Pfizer Inc.
    10. Biogen
    TIPRE00004066
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.